What type of study is this?

October 23, 2025Journal of Craniofacial Surgery

Bisphosphonate Therapy for Fibrous Dysplasia of The Jaw in Children

View Full Paper

Ask AI

Bookmark

Intravenous zoledronic acid significantly improved symptoms in the child with fibrous dysplasia.
The patient, a 6-year-old child, suffered from severe bone pain and trismus due to lesions.
Monostotic fibrous dysplasia commonly affects the mandible, particularly in children under five.
Effective medical management suggests potential for broader treatment strategies in pediatric fibrous dysplasia.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Case report demonstrates medical management of monostotic fibrous dysplasia in children, indicating that zoledronic acid can reduce bone pain and symptoms.

Cite This Study

Tomar et al. (2025) studied this question.

synapsesocial.com/papers/68f9bad6d7353cfcfc68f507 https://doi.org/10.1097/scs.0000000000012037

View Full Paper

Ask AI

Bookmark

Implication

Case report demonstrates medical management of monostotic fibrous dysplasia in children, indicating that zoledronic acid can reduce bone pain and symptoms.

Bisphosphonate Therapy for Fibrous Dysplasia of The Jaw in Children

Key Points

Discussion

Implication

Cite This Study

Bisphosphonate Therapy for Fibrous Dysplasia of The Jaw in Children

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider